3T Biosciences is a series a startup. 1 investor tracked. Status: possibledead.
3T Biosciences is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
3T Biosciences is a company focused on discovering and developing novel therapies for cancer treatment. They leverage their 3T-Trace platform to identify and target cancer-specific antigens, aiming to develop personalized immunotherapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.